FLG2 and peeling skin syndrome: Clonal proliferations exceeding 10% were also detected for two out of four controls, pSS6 and pSS7, though the clonal proliferations did not remain present in the follow up biopsy for pSS6, suggesting dominant clonal proliferations in pSS patients who do not develop eMZL may be transient in nature.